DE60107135D1 - Stuhl-Marker - Google Patents

Stuhl-Marker

Info

Publication number
DE60107135D1
DE60107135D1 DE60107135T DE60107135T DE60107135D1 DE 60107135 D1 DE60107135 D1 DE 60107135D1 DE 60107135 T DE60107135 T DE 60107135T DE 60107135 T DE60107135 T DE 60107135T DE 60107135 D1 DE60107135 D1 DE 60107135D1
Authority
DE
Germany
Prior art keywords
stool
colon
marker
chair
marked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60107135T
Other languages
English (en)
Other versions
DE60107135T2 (de
Inventor
Kevin Tait
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
K B A S Pty Ltd
Original Assignee
K B A S Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K B A S Pty Ltd filed Critical K B A S Pty Ltd
Application granted granted Critical
Publication of DE60107135D1 publication Critical patent/DE60107135D1/de
Publication of DE60107135T2 publication Critical patent/DE60107135T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Finger-Pressure Massage (AREA)
  • Chairs Characterized By Structure (AREA)
  • Toilet Supplies (AREA)
DE60107135T 2000-03-07 2001-03-07 Stuhl-Marker Expired - Lifetime DE60107135T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ605500 2000-03-07
AUPQ6055A AUPQ605500A0 (en) 2000-03-07 2000-03-07 Stool marker

Publications (2)

Publication Number Publication Date
DE60107135D1 true DE60107135D1 (de) 2004-12-23
DE60107135T2 DE60107135T2 (de) 2005-11-10

Family

ID=3820159

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60107135T Expired - Lifetime DE60107135T2 (de) 2000-03-07 2001-03-07 Stuhl-Marker

Country Status (6)

Country Link
US (1) US6726896B2 (de)
EP (1) EP1138331B1 (de)
AT (1) ATE282419T1 (de)
AU (1) AUPQ605500A0 (de)
DE (1) DE60107135T2 (de)
ES (1) ES2233565T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498018B2 (en) * 2003-10-03 2009-03-03 Bracco Diagnostics Inc. Contrast media for use in medical and diagnostic procedures and methods of using the same
CN100400105C (zh) * 2006-05-11 2008-07-09 上海交通大学 水性基质的消化道ct阴性造影剂及其制备方法
EP2182856A2 (de) 2007-08-08 2010-05-12 Brian J. Cavanaugh Verfahren und vorrichtung für ligaturnaht

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935099A (en) * 1974-04-03 1976-01-27 The United States Of America As Represented By The Secretary Of Agriculture Method of reducing water content of emulsions, suspensions, and dispersions with highly absorbent starch-containing polymeric compositions
FR2352544A1 (fr) * 1976-05-26 1977-12-23 Roussel Uclaf Nouveau medicament pour opacification barytee et procede de preparation de ce nouveau medicament
AU578026B2 (en) * 1983-06-09 1988-10-13 Field Group Chemicals Pty. Ltd. Radiopaque medium
US5460798A (en) 1992-06-22 1995-10-24 Barnett; Patrick A. System for determining the quantity and identity of material ingested by user
JP3332426B2 (ja) 1992-10-02 2002-10-07 太田製薬株式会社 大腸および小腸の検査用ｘ線造影剤
US5326553A (en) 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JPH08217697A (ja) 1995-02-13 1996-08-27 Sakai Chem Ind Co Ltd 消化管追跡用マーカー及びその製造方法
JP3717007B2 (ja) * 1995-12-08 2005-11-16 和三 平井 新規なバリウム粉末製剤、それを用いた上部消化管造影用極超高濃度バリウム懸濁液、およびこれらの製造方法
GB9603547D0 (en) 1996-02-20 1996-04-17 Nycomed Imaging As Contrast media

Also Published As

Publication number Publication date
ATE282419T1 (de) 2004-12-15
US20010036442A1 (en) 2001-11-01
EP1138331B1 (de) 2004-11-17
AUPQ605500A0 (en) 2000-03-30
ES2233565T3 (es) 2005-06-16
EP1138331A2 (de) 2001-10-04
DE60107135T2 (de) 2005-11-10
EP1138331A3 (de) 2003-02-05
US6726896B2 (en) 2004-04-27

Similar Documents

Publication Publication Date Title
ATE526950T1 (de) Hydrocodon-formulierungen mit gesteuerter freisetzung
MX9200992A (es) Composicion farmaceutica que tiene como ingrediente activo 3-[2-(dimetilamino)etil]-n-metil-1h-indol-5-metanosulfonamida y procedimiento para su preparacion.
AU7888398A (en) Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
HUP9700322A2 (hu) Hosszabb lokálanesztézist biztosító készítmény és módszerek
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
PT1083879E (pt) Metodos e dispositivos para proporcionar uma terapia de drogas prolongada
DE60121303D1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
CY1111869T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι χρησιμες για την αντιμετωπιση του καρκινου ή της ηπατικης ινωσης
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
ATE282419T1 (de) Stuhl-marker
BR0008952A (pt) Composição de preparação de iodo
DE69326627D1 (de) Therapeutisches Mittel gegen drohenden Abortus
HK1054198A1 (en) Novel use of (R)-(-)-2-Ä5-(4-fluorophenyl)-3-pyridylmethylaminomethylÜ-chromane and its physiologically acceptable salts.
DE60216292D1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
RU96115138A (ru) Применение диметикона для лечения запоров
IL164763A0 (en) Byperforin derivatives, the use thereof and formulations containing them
CN108371623A (zh) 阿是穴臀部按摩仪
KR970019821A (ko) 송진을 함유한 치약 제조 방법
CN108371621A (zh) 阿是穴肘部按摩仪
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
Yun-Ju et al. Palatoplasty using Wardill & Kilner VY Pushback Palatal Flap in Secondary Cleft Palate
King Tumor necrosis factor, interleukin-1 and tissue oxygen levels in myofascial pain and fibromyalgia patients

Legal Events

Date Code Title Description
8364 No opposition during term of opposition